Dishman Carbogen Amcis Limited (NSE:DCAL)
India flag India · Delayed Price · Currency is INR
164.23
-0.44 (-0.27%)
At close: Mar 6, 2026

Dishman Carbogen Amcis Company Description

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide.

The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments.

It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics.

The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Dishman Carbogen Amcis Limited
Country India
Founded 1983
Industry Biotechnology
Sector Healthcare
Employees 1,106
CEO Arpit Vyas

Contact Details

Address:
Dishman Corporate House
Ahmedabad, Gujarat 380058
India
Phone 91 27 1742 0102
Website imdcal.com

Stock Details

Ticker Symbol DCAL
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE385W01011
SIC Code 2833

Key Executives

Name Position
Dr. Himani S. Dhotre Chief Executive Officer of Projects and Operations
Arpit Janmejay Vyas Global MD and Director
Deohooti Janmejay Vyas Whole Time Director
Harshil R. Dalal Global Chief Financial Officer
Paolo Armanino Chief Operating Officer of Indian Operations
Shrima Gaurangbhai Dave Compliance Officer and Company Secretary
Dharmesh Desai GM of Secretarial and Legal
Lucie Framinet Marketing Manager
Dr. Alan Fischer Ph.D. Chief Technology Officer of CARBOGEN AMCIS
Dr. Martin Schneider Ph.D. Chief Quality and Compliance Officer of CARBOGEN AMCIS